// Auto-generated search index - do not edit
const SEARCH_INDEX = [
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html",
    "section": "Core Specification",
    "keywords": "THAT reduction reagent characteristics biological replicate source name CT developmental stage TIP PURPOSE CV spiked compound HCD FDR VCF WARRANTY sample cleavage agent details FITNESS RECOMMEND disease stage INITIATIVE MINOR MHC PTM XML PARTICULAR CLO cell type EFO DIA RECOMMENDED BE PRIDE:0000659 PATCH NOT SILAC ... ZFA OF DISCLAIMS IDF URI PROTEOMICS PS PEPTIDESEQ EBI TO DDA INCLUDING SDRF CL HTML organism PSI CS REQUIRES fraction identifier SP CN CID README depletion technical replicate DTT THE RIGHTS BMC EXPRESS OR HEREIN MS:1001251 replicate MAJOR MOD CF TAB DOID PRM URL USE PMCID BUT PMID RFC CPTAC IMPORTANT LC age MONDO HUPO source name_ and _assay name label MERCHANTABILITY alkylation reagent SH UBERON ancestry category ID fractionation method data file VK exclamation PO XL ROW IAA OPTIONAL proteomics data acquisition method ISA MAGE PATO AC COLUMN organism part individual COULD PP dissociation method MAY ENVO MT SWATH INFRINGE TMT WILL HF MUST collision energy NT INFORMATION JA disease MC MS III BRENDA STANDARDS LIMITED EM HANCESTRO ALL WARRANTIES FOR file your SHALL instrument REQUIRED SN SRM NOTE LI BTO NCBI QY mass sex EW PRIDE CELL pooled sample MIAME biosample accession number TA SHOULD IMPLIED NCE AS IS ANY II RAW DJ"
  },
  {
    "title": "Sample and Data Relationship Format for Proteomics (SDRF-Proteomics)",
    "content": "// suppress inspection \"GrazieInspection\" for whole file\nSample and Data Relationship Format for Proteomics (SDRF-Proteomics)\n\n//only works on some backends, not HTML\n\n//use style like Section 1 when referencing within the document.\n\n//GitHub specific settings\n\nStatus of this document\n\nThis document provides information to the proteomics community about a proposed standard for sample metadata annotations in public repositories called Sample and Data Relationship File (SDRF)-Proteomics format. Distribution is unlimited.\n\nVersion v1.1.0 - 2025-01\n\nAbstract\n\nThe Human Proteome Organisation (HUPO) Proteomics Standards Initiative (PSI) defines community standards for data representation in proteomics to facilitate data comparison, exchange, and verification. This document presents a specification for the Sample and Data Relationship Format (SDRF-Proteomics).\n\nFurther detailed information, including any updates to this document, implementations, and examples is available at SDRF GitHub Repository. The official PSI web page for the document is the following: \n\nMotivation\n\nMany resources have emerged that provide raw or integrated proteomics data in the public domain. If these are valuable individually, their integration through re-analysis represents a huge asset for the community [1].\n\nUnfortunately, proteomics experimental design and sample related information are often missing in public repositories or stored in very diverse ways and formats. For example:\n\n- The CPTAC Consortium provides for every dataset a set of Excel files with the information on each sample including tumor size, origin, but also how every sample is related to a specific raw file (e.g. instrument configuration parameters).\n\n- As a resource routinely re-analysing public datasets, ProteomicsDB, captures for each sample in the database a minimum number of properties to describe the sample and the related experimental protocol such as tissue, digestion method and instrument.\n\nSuch heterogeneity often pre",
    "url": "./specification.html#sample-and-data-relationship-format-for-proteomics-sdrf-proteomics",
    "section": "Core Specification",
    "keywords": "THAT reduction reagent biological replicate CT PURPOSE CV spiked compound HCD FDR VCF WARRANTY cleavage agent details FITNESS RECOMMEND disease stage INITIATIVE MINOR MHC PTM PARTICULAR CLO cell type EFO DIA RECOMMENDED BE PRIDE:0000659 PATCH NOT SILAC ... ZFA OF DISCLAIMS IDF URI PROTEOMICS PS PEPTIDESEQ EBI TO DDA INCLUDING SDRF CL HTML organism PSI CS REQUIRES fraction identifier SP CN CID README depletion technical replicate DTT THE RIGHTS BMC EXPRESS OR HEREIN MS:1001251 MAJOR MOD CF TAB DOID PRM URL USE PMCID BUT PMID RFC CPTAC LC age MONDO HUPO label MERCHANTABILITY alkylation reagent SH UBERON ancestry category fractionation method data file VK PO XL ROW IAA OPTIONAL proteomics data acquisition method ISA MAGE PATO AC COLUMN organism part individual COULD PP dissociation method MAY ENVO MT SWATH INFRINGE TMT WILL HF MUST collision energy NT INFORMATION JA disease MC MS III BRENDA STANDARDS LIMITED EM HANCESTRO ALL WARRANTIES FOR SHALL instrument REQUIRED SN SRM LI BTO NCBI QY mass sex EW PRIDE CELL pooled sample MIAME biosample accession number TA SHOULD IMPLIED NCE AS IS ANY II RAW DJ"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html",
    "section": "Sample Metadata Guidelines",
    "keywords": "CL:0000898 biological replicate CL:0000576 CL:0000624 source name developmental stage TIP CL:0000815 CSF UBERON:0002113 UBERON:0002097 MONDO:0005180 DSS CL:0000540 CL:0000813 UBERON:0002107 PTM cell type EFO PATO:0000383 MONDO:0005105 CL:0000233 UBERON:0001155 UBERON:0001969 MONDO:0008383 SDRF CL organism depletion APP PATO:0000461 MONDO:0005148 CL:0000232 UBERON:0000178 UBERON:0001359 DOID CL:0000787 CL:0000625 MONDO:0100096 URL CL:0000236 UBERON:0000955 MONDO:0004975 IMPORTANT CL:0000235 age MONDO CML CL:0000066 CL:0000788 MONDO:0004946 CL:0000623 xenograft lib UBERON MONDO:0005301 ID ancestry category exclamation PO compound UBERON:0001088 MONDO:0005138 COVID PATO organism part individual MAY PATO:0000384 PATO:0001340 CL:0000451 synthetic peptide MUST UBERON:0000310 disease disease model CL:0000057 UBERON:0000948 HANCESTRO ALL enrichment process MONDO:0004989 NOTE NCBI CL:0000913 NK UBERON:0002048 sex UBERON:0001977 SHOULD NSG CL:0000182 MONDO:0005575 CL:0000084 PDX"
  },
  {
    "title": "Sample Metadata Guidelines",
    "content": "Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating general sample metadata in SDRF-Proteomics format. These guidelines apply to samples from any organism (human, animal, plant).\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nSample metadata guidelines define standardized formats for common properties that apply across all organism types. This guideline covers:\n\n- Organism annotation\n- Organism part / tissue annotation\n- Age and temporal information\n- Biological sex\n- Disease and health status\n- Developmental stage\n- Cell type annotation\n\nFor human-specific metadata (disease staging, comorbidities, treatment history, demographics, lifestyle factors), see Human Sample Metadata Guidelines.\n\nOrganism Annotation\n\nColumn\n\ncharacteristics[organism]\n\nOntology\n\n- Primary: NCBI Taxonomy (NCBITaxon)\n- Alternative: EFO\n\nFormat\n\nUse the scientific name in lowercase:\n\nValue |NCBITaxon ID |Description\n\nhomo sapiens\nNCBITaxon:9606\nHuman\n\nmus musculus\nNCBITaxon:10090\nMouse\n\nrattus norvegicus\nNCBITaxon:10116\nRat\n\ndanio rerio\nNCBITaxon:7955\nZebrafish\n\ndrosophila melanogaster\nNCBITaxon:7227\nFruit fly\n\ncaenorhabditis elegans\nNCBITaxon:6239\nNematode worm\n\nsaccharomyces cerevisiae\nNCBITaxon:4932\nBaker's yeast\n\narabidopsis thaliana\nNCBITaxon:3702\nThale cress\n\n Use lowercase for organism names. The validator will map to the correct ontology term.\n\nOrganism Part / Tissue Annotation\n\nColumn\n\ncharacteristics[organism part]\n\nOntologies\n\nOrganism Type |Ontology |URL\n\nMammals/Vertebrates\nUBERON\n\nPlants\nPlant Ontology (PO)\n\nDrosophila\nFlyBase Anatomy (FBbt)\n\nC. elegans\nWormBase Anatomy (WBbt)\n\nCommon Values\n\nValue |UBERON ID |Description\n\nblood\nUBERON:0000178\nWhole blood\n\nblood plasma\nUBERON:0001969\nPlasma fraction\n\nblood serum\nUBERON:0001977\nSerum fraction\n\nliver\nUBERON:0002107\nLiver tissue\n\nbrain\nUBERON:0000955\nBrain tissue\n\nheart\nUBERON:0000948\nHeart tissue\n\nkidney\nUBERON:0002113\nKidney tissue\n\nlung\nUBERON:0002048\nLung tissue\n\nskin\nUBERON:0002097\nSkin ti",
    "url": "./metadata-guidelines/sample-metadata.html#sample-metadata-guidelines",
    "section": "Sample Metadata Guidelines",
    "keywords": "CL:0000898 biological replicate CL:0000576 CL:0000624 source name developmental stage CL:0000815 CSF UBERON:0002113 UBERON:0002097 MONDO:0005180 DSS CL:0000540 CL:0000813 UBERON:0002107 PTM cell type EFO PATO:0000383 MONDO:0005105 CL:0000233 UBERON:0001155 UBERON:0001969 MONDO:0008383 SDRF CL organism depletion APP PATO:0000461 MONDO:0005148 CL:0000232 UBERON:0000178 UBERON:0001359 DOID CL:0000787 CL:0000625 MONDO:0100096 URL CL:0000236 UBERON:0000955 MONDO:0004975 CL:0000235 age MONDO CML CL:0000066 CL:0000788 MONDO:0004946 CL:0000623 xenograft UBERON MONDO:0005301 ID ancestry category PO compound UBERON:0001088 MONDO:0005138 COVID PATO organism part individual MAY PATO:0000384 PATO:0001340 CL:0000451 synthetic peptide MUST UBERON:0000310 disease disease model CL:0000057 UBERON:0000948 HANCESTRO ALL enrichment process MONDO:0004989 NCBI CL:0000913 NK UBERON:0002048 sex UBERON:0001977 SHOULD NSG CL:0000182 MONDO:0005575 CL:0000084 PDX"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html",
    "section": "Human Metadata Guidelines",
    "keywords": "body mass index NCIT:C27966 IV PR Ann Arbor stage NCIT:C81327 TNM staging pregnancy status MONDO:0005044 disease stage HANCESTRO:0006 time post treatment secondary condition NCIT:C53554 NCIT:C28054 NCIT:C27970 BMI EFO smoking status NCIT:C81328 NCIT:C15445 NCIT:C14174 AJCC NCIT:C15313 NCIT:C53555 NCIT:C53553 pre-existing condition SDRF ACE organism PREFERRED NCIT:C16358 treatment response treatment MONDO:0005148 MONDO:0004979 MONDO:0005300 ethnicity NCIT:C68804 NCIT:C53556 NCIT NCIT:C62723 MONDO:0004995 IMPORTANT MONDO:0011122 gestational age age CHEBI:27899 MONDO CHEBI:28748 NCIT:C65106 NCIT:C15329 breast cancer subtype HIPAA treatment status ancestry category ID PD NCIT:C18213 exclamation TNM NCIT:C65107 sampling time point compound individual organism part NCIT:C14169 NCIT:C28078 HANCESTRO:0005 diet CHEBI:41774 GDPR NCIT:C18206 NCIT:C71732 HANCESTRO:0010 menopausal status Dukes stage alcohol consumption disease HANCESTRO:0009 NCIT:C14167 III NCIT:C18058 UO NCI tumor grade HANCESTRO NCIT:C15262 ER prior treatment NOTE MONDO:0002050 dose height NCIT:C28079 CHEBI:6801 NCIT:C4870 medication history NCIT:C27971 sex NCIT:C28076 NCIT:C28077 NCIT:C14168 NCIT:C65108 weight II NCIT:C15632"
  },
  {
    "title": "Human Sample Metadata Guidelines",
    "content": "Human Sample Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating human-specific metadata in SDRF-Proteomics format. These guidelines apply to all human samples, including both clinical studies and healthy individuals.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nHuman-specific metadata is crucial for interpreting proteomics data from human samples, enabling stratification by clinical and demographic characteristics and integration with other biomedical datasets. This guideline defines standardized approaches for annotating human-specific metadata:\n\n- Disease staging and grading\n- Pre-existing conditions and comorbidities\n- Treatment and medication history\n- Individual/patient identifiers\n- Additional clinical metadata (BMI, lifestyle factors, reproductive status)\n\nFor general sample metadata guidelines (age, biological sex, basic disease annotation) that apply to all organisms, see Sample Metadata Guidelines.\n\nDisease Staging and Grading\n\nDisease staging and grading are primarily used for human cancers and other progressive diseases.\n\nDisease Stage\n\nColumn\n\ncharacteristics[disease stage]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n- Alternative: EFO\n\nStandard Values\n\nValue |NCIT ID |Description\n\nstage I\nNCIT:C27966\nEarly localized disease\n\nstage II\nNCIT:C28054\nLocally advanced\n\nstage III\nNCIT:C27970\nRegional spread\n\nstage IV\nNCIT:C27971\nDistant metastasis\n\nearly\n\nGeneral early stage\n\nadvanced\n\nGeneral advanced stage\n\nlocalized\nNCIT:C68804\nConfined to primary site\n\nmetastatic\nNCIT:C14174\nHas spread to distant sites\n\nnot available\n\nStage unknown\n\nnot applicable\n\nStaging not relevant (non-cancer)\n\nCancer-Specific Staging\n\nTNM Staging\n\nColumn\n\ncharacteristics[TNM staging]\n\nOntology\n\n- Primary: NCI Thesaurus (NCIT)\n\nFormat\n\nT{0-4}N{0-3}M{0-1}\n\nComponents:\n\n- T: Primary tumor size/extent (T0-T4, Tis for in situ)\n- N: Regional lymph node involvement (N0-N3)\n- M: Distant metastasis (M0, M1)\n\nPrefix p indicates pathological staging (e.g., pT",
    "url": "./metadata-guidelines/human-metadata.html#human-sample-metadata-guidelines",
    "section": "Human Metadata Guidelines",
    "keywords": "body mass index NCIT:C27966 IV PR Ann Arbor stage NCIT:C81327 TNM staging pregnancy status MONDO:0005044 disease stage HANCESTRO:0006 time post treatment secondary condition NCIT:C53554 NCIT:C28054 NCIT:C27970 BMI EFO smoking status NCIT:C81328 NCIT:C15445 NCIT:C14174 AJCC NCIT:C15313 NCIT:C53555 NCIT:C53553 pre-existing condition SDRF ACE organism PREFERRED NCIT:C16358 treatment response treatment MONDO:0005148 MONDO:0004979 MONDO:0005300 ethnicity NCIT:C68804 NCIT:C53556 NCIT NCIT:C62723 MONDO:0004995 MONDO:0011122 gestational age age CHEBI:27899 MONDO CHEBI:28748 NCIT:C65106 NCIT:C15329 breast cancer subtype HIPAA treatment status ancestry category ID PD NCIT:C18213 TNM NCIT:C65107 sampling time point compound individual organism part NCIT:C14169 NCIT:C28078 HANCESTRO:0005 diet CHEBI:41774 GDPR NCIT:C18206 NCIT:C71732 HANCESTRO:0010 menopausal status Dukes stage alcohol consumption disease HANCESTRO:0009 NCIT:C14167 III NCIT:C18058 UO NCI tumor grade HANCESTRO NCIT:C15262 ER prior treatment MONDO:0002050 dose height NCIT:C28079 CHEBI:6801 NCIT:C4870 medication history NCIT:C27971 sex NCIT:C28076 NCIT:C28077 NCIT:C14168 NCIT:C65108 weight II NCIT:C15632"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html",
    "section": "Data File Metadata Guidelines",
    "keywords": "scan window lower limit scan window upper limit UNIMOD:4 label MS:1001306 modification parameters MSD DDA MS:1001303 MS1 scan range file uri SDRF ID TIP TOF fraction data file exclamation PSI CS XL sample fraction identifier KR proteomics data acquisition method instrument REQUIRED SRM FTP cleavage agent details technical replicate MS:1001309 URL SCIEX NOTE AC MS2 analyzer type MS:1001251 UNIMOD:1 MS:1001917 PRIDE:0000663 PP MOD CF MGF ST ELISA MT fragment mass tolerance PRIDE PRM TMT UNIMOD:21 TS RPPA DIA HF UNIMOD:737 RECOMMENDED MRM UNIMOD TA SHOULD UNIMOD:35 SILAC MM MUST IMPORTANT MS:1001313 NT precursor mass tolerance proteomexchange accession number URI RAW LTQ MS"
  },
  {
    "title": "Data File Metadata Guidelines",
    "content": "Data File Metadata Guidelines\n\nStatus of this Guideline\n\nThis document provides guidelines for annotating data file metadata in SDRF-Proteomics format. These guidelines define standardized approaches for describing MS run files, instrument settings, and analysis parameters.\n\nVersion 1.0.0 - 2025-01\n\nAbstract\n\nData file metadata guidelines define standardized formats for properties that describe the relationship between samples and data files, instrument configurations, and analysis parameters. This guideline covers:\n\n- Assay name and data file identification\n- Label annotations for multiplexed experiments\n- Instrument type and model\n- Technology type\n- Protein modifications\n- Cleavage agents\n- Mass tolerances\n\nFor sample metadata guidelines (organism, age, sex, disease), see Sample Metadata Guidelines.\n\nCore Data File Columns\n\nThe connection between samples and data files is done using properties annotated with the comment prefix. The use of comment differentiates data file properties from sample properties (characteristics).\n\nColumn Order\n\nThe order of columns is important:\n\n1. assay name SHOULD always be located before the comments\n2. technology type SHOULD be placed immediately after assay name\n3. comment[data file] is RECOMMENDED as the last column\n\nAssay Name\n\nColumn\n\nassay name\n\nDescription\n\nAssay name is a unique identifier for an MS run (data file). Each distinct MS run/data file MUST have exactly one globally unique assay name, and no two different data files may share an assay name.\n\nUniqueness Rules\n\n The combination of source name + assay name + comment[label] MUST be unique within the SDRF file.\n\nRule |Requirement |Description\n\nassay name uniqueness\nMUST\nEach data file has exactly one unique assay name\n\nsource name + assay name\nRECOMMENDED\nShould be unique (warning if not)\n\nsource name + assay name + comment[label]\nMUST\nRequired unique combination\n\nExamples\n\nFormat |Example |Use Case\n\nsamplerun\nsample1run1\nSimple naming\n\nsamplefractionreplicate\nsample1F",
    "url": "./metadata-guidelines/data-file-metadata.html#data-file-metadata-guidelines",
    "section": "Data File Metadata Guidelines",
    "keywords": "scan window lower limit scan window upper limit UNIMOD:4 label MS:1001306 modification parameters MSD DDA MS:1001303 MS1 scan range file uri SDRF ID TOF data file PSI CS XL fraction identifier KR proteomics data acquisition method instrument REQUIRED SRM FTP cleavage agent details technical replicate MS:1001309 URL SCIEX AC MS2 analyzer type MS:1001251 UNIMOD:1 MS:1001917 PRIDE:0000663 PP MOD CF MGF ST ELISA MT fragment mass tolerance PRIDE PRM TMT UNIMOD:21 TS RPPA DIA HF UNIMOD:737 RECOMMENDED MRM UNIMOD TA SHOULD UNIMOD:35 SILAC MM MUST MS:1001313 precursor mass tolerance NT proteomexchange accession number URI RAW LTQ MS"
  }
];
